Rhumbline Advisers »

Apogee Therapeutics shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.7M 56k 66.45
2023-12-31 $761k 27k 27.94
2023-09-30 $561k 26k 21.30